Literature DB >> 12385035

Interactions of antimitotic peptides and depsipeptides with tubulin.

Ernest Hamel1.   

Abstract

Tubulin is the target for an ever increasing number of structurally unusual peptides and depsipeptides isolated from a wide range of organisms. Since tubulin is the subunit protein of microtubules, the compounds are usually potently toxic to mammalian cells. Without exception, these (depsi)peptides disrupt cellular microtubules and prevent spindle formation. This causes cells to accumulate at the G2/M phase of the cell cycle through inhibition of mitosis. In biochemical assays, the compounds inhibit microtubule assembly from tubulin and suppress microtubule dynamics at low concentrations. Most of the (depsi)peptides inhibit the binding of Catharanthus alkaloids to tubulin in a noncompetitive manner, GTP hydrolysis by tubulin, and nucleotide turnover at the exchangeable GTP site on beta-tubulin. In general, the (depsi)peptides induce the formation of tubulin oligomers of aberrant morphology. In all cases tubulin rings appear to be formed, but these rings differ in diameter, depending on the (depsi)peptide present during their formation. Published 2002 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12385035     DOI: 10.1002/bip.10255

Source DB:  PubMed          Journal:  Biopolymers        ISSN: 0006-3525            Impact factor:   2.505


  8 in total

Review 1.  Issues related to targeted delivery of proteins and peptides.

Authors:  Yingjuan Lu; Jun Yang; Emanuela Sega
Journal:  AAPS J       Date:  2006-07-21       Impact factor: 4.009

2.  Therapeutic Efficacy of a Family of pHLIP-MMAF Conjugates in Cancer Cells and Mouse Models.

Authors:  Kelly E Burns; Harvey Hensley; Matthew K Robinson; Damien Thévenin
Journal:  Mol Pharm       Date:  2017-01-13       Impact factor: 4.939

3.  Biological Characterization of an Improved Pyrrole-Based Colchicine Site Agent Identified through Structure-Based Design.

Authors:  Cristina C Rohena; Nakul S Telang; Chenxiao Da; April L Risinger; James A Sikorski; Glen E Kellogg; John T Gupton; Susan L Mooberry
Journal:  Mol Pharmacol       Date:  2015-12-11       Impact factor: 4.436

4.  Biological evaluation of tubulysin A: a potential anticancer and antiangiogenic natural product.

Authors:  Gurmeet Kaur; Melinda Hollingshead; Susan Holbeck; Vesna Schauer-Vukasinović; Richard F Camalier; Alexander Dömling; Seema Agarwal
Journal:  Biochem J       Date:  2006-06-01       Impact factor: 3.857

5.  Analysis of the cryptophycin P450 epoxidase reveals substrate tolerance and cooperativity.

Authors:  Yousong Ding; Wolfgang H Seufert; Zachary Q Beck; David H Sherman
Journal:  J Am Chem Soc       Date:  2008-03-26       Impact factor: 15.419

6.  Evolution of the total syntheses of ustiloxin natural products and their analogues.

Authors:  Pixu Li; Cory D Evans; Yongzhong Wu; Bin Cao; Ernest Hamel; Madeleine M Joullié
Journal:  J Am Chem Soc       Date:  2008-01-30       Impact factor: 15.419

7.  Fenbendazole acts as a moderate microtubule destabilizing agent and causes cancer cell death by modulating multiple cellular pathways.

Authors:  Nilambra Dogra; Ashok Kumar; Tapas Mukhopadhyay
Journal:  Sci Rep       Date:  2018-08-09       Impact factor: 4.379

Review 8.  Recent Advances in Small Peptides of Marine Origin in Cancer Therapy.

Authors:  Qi-Ting Zhang; Ze-Dong Liu; Ze Wang; Tao Wang; Nan Wang; Ning Wang; Bin Zhang; Yu-Fen Zhao
Journal:  Mar Drugs       Date:  2021-02-19       Impact factor: 5.118

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.